Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON36966
NL-OMON36966
Completed
Not Applicable

Selection of Breast Cancer Patients with Low-risk Tumors using MR Imaging - Patient Risk based on Functional MRI/ PROFILE

niversitair Medisch Centrum Utrecht0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
60
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • •\- 18 years or older
  • •\- Female patients
  • •\- Eligible for breast\-conserving therapy

Exclusion Criteria

  • •\- Any prior surgery or radiotherapy to the ipsilateral breast
  • •\- Patients planned for neoadjuvant chemotherapy
  • •\- Karnofsky score \<\= 70
  • •\- Pregnant or lactating women
  • •\- Contra\-indications to MRI scanning
  • •Contra\-indications to injection of gadolinium based contrast agent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Epirubicin/Paclitaxel/Cyclophosphamide-Methotrexate-Fluorouracil (E-T-CMF) as adjuvant chemotherapy in high-risk patients with operable breast cancerBreast CancerCancer - Breast
ACTRN12615000161527Hellenic Cooperative Oncology Group1,000
Completed
Not Applicable
Investigation of the prognostic role of protein expression, mRNA levels, gene amplification and mutation of key cellular elements in patients with breast cancer treated with dose-dense sequential adjuvant chemotherapyBreast CancerCancer - Breast
ACTRN12616001043426Hellenic Cooperative Oncology Group1,060
Completed
Phase 3
Epirubicin-Paclitaxel-Cyclophosphamide Methotrexate Fluorouracil (E-T-CMF) versus Epirubicin-Cyclophosphamide Methotrexate Fluorouracil (E-CMF) as adjuvant chemotherapy in high risk patients with operable breast cancer. A phase III study conducted by the Hellenic Cooperative Oncology Group (HE10/97)
ACTRN12611000506998Hellenic Cooperative Oncology Group600
Completed
Not Applicable
Prevention of breast cancer in high risk women by monitoring microrna expression in nipple aspirate fluid.breast cancerbreast carcinoma100836241000629110006232
NL-OMON44762niversitair Medisch Centrum Utrecht720
Completed
Phase 3
Clinically node negative breast cancer patients undergoing breast conserving therapy: Sentinel lymph node procedure versus follow-up. A Dutch randomized controlled multicentre trial.breast cancersentinel lymph node metastasessentinel lymph nodes1000629110006295
NL-OMON54499Medisch Universitair Ziekenhuis Maastricht1,730